Prothena Corp Public (PRTA) Enterprise Value Growth (1y) (2013 - 2026)
Prothena Corp Public (PRTA) Enterprise Value Growth (1y) (2013 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Prothena Corp Public | 458.13 Mn | 128.67 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 21.17% |
| Dec 31, 2025 | 34.76% |
| Sep 30, 2025 | 36.29% |
| Jun 30, 2025 | 34.16% |
| Mar 31, 2025 | 23.72% |
| Dec 31, 2024 | 23.99% |
| Sep 30, 2024 | 22.76% |
| Jun 30, 2024 | 14.59% |
| Mar 31, 2024 | 20.16% |
| Dec 31, 2023 | 12.70% |
| Sep 30, 2023 | -35.64% |
| Jun 30, 2023 | -29.81% |
| Mar 31, 2023 | -26.37% |
| Dec 31, 2022 | -22.68% |
| Sep 30, 2022 | 17.41% |
| Jun 30, 2022 | -26.82% |
| Mar 31, 2022 | -57.69% |
| Dec 31, 2021 | -95.16% |
| Sep 30, 2021 | -89.98% |
| Jun 30, 2021 | -20.14% |